Long term survival with adjuvant immunotherapy after neoadjuvant chemoimmunotherapy and esophagectomy in locally advanced ESCC
Postoperative adjuvant immunotherapy (aIT) represents a strategy for locally advanced esophageal squamous cell carcinoma (LA-ESCC) treated with neoadjuvant chemoimmunotherapy (nCIT) followed by esophagectomy. This multicenter retrospective cohort enrolled 418 Chinese LA-ESCC patients treated with nCIT followed by esophagectomy, split into aIT and surveillance groups. We balanced baseline confounders via 1:1 propensity score matching (PSM) and analyzed overall survival (OS) and event-free survival (EFS). With a median 48.7-month follow-up, aIT was associated with higher 4-year OS among matched patients (78.21% vs. 65.20%, HR=0.571, p = 0.012), while EFS (64.45% vs. 59.46%, HR=0.735, p = 0.114) showed no intergroup difference. The observed OS association with aIT was limited to patients without major pathological response (non-MPR). In this retrospective cohort, postoperative aIT was associated with longer overall survival specifically among non-MPR LA-ESCC patients following nCIT.
Authors
- Xiaomin Wang (ORCID: https://orcid.org/0000-0003-0336-5526)
- Hong Ge (ORCID: https://orcid.org/0000-0002-2958-3866)
- Bingxu Li (ORCID: https://orcid.org/0000-0001-5499-1303)
- Baosheng Li (ORCID: https://orcid.org/0000-0002-3225-5740)
- Wencheng Zhang
- Huai Liu
- Xiaoli Zheng
- Shuhan Yang (ORCID: https://orcid.org/0009-0004-5838-2408)
- Yumeng Xiao
- Zifan Qin
- Hui Wang
- Wei Huang
Institutions
- Central South University (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Zhengzhou University (CN)
- Shandong Tumor Hospital (CN)
- Hunan Cancer Hospital (CN)
- Henan Cancer Hospital (CN)
- Anyang Tumor Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- iScience
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1016/j.isci.2026.118247
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00